Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumors

Topics in Magnetic Resonance Imaging

Volumn 10, Issue 2, 1999, Pages 104-113

  Castillo, Mauricio ^a,b   Kwock, Lester ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HUMAN; INTRACRANIAL TUMOR; LYMPHOMA; MEDULLOBLASTOMA; MENINGIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0032759646     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-199904000-00003     Document Type: Article

References (42)

1. Castillo M, Kwock L, Scatliff J, Mukherji SK. Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. MRI Clin North Am 1998;6:1-20.
2. Kwock L. Clinical proton magnetic resonance spectroscopy: Basic principles. In: Mukherji SK, ed. Clinical applications of MR spectroscopy. New York: Wiley-Liss, 1998:1-32.
3. Kwock L. Localized MR spectroscopy: basic principles. Neuroimaging Clin North Am 1998;8:713-32.
4. Richards TL, Dager SR, Posse S. Functional MR spectroscopy of the brain. Neuroimaging Clin North Am 1998;8:823-34.
5. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR 1996;17:1-15.
6. Castillo M, Kwock L. Proton MR spectroscopy of common brain tumors. Neuroimaging Clin North Am 1998;8:733-52.
7. Kwock L, Brown MA, Castillo M. Extraneous lipid contamination in single-volume proton spectroscopy: Phantom and human studies. AJNR 1997;18:1349-57.
8. Okazaki H. Fundamentals of neuropathology. Morphologic basis of neurologic disease, 2nd ed. New York: Igaku Shoin, 1989:203-5.
9. Parisi JE, Scheithauer BW. Glial tumors. In: Nelson JS, Parisi JE, Shochet SS, eds. Principles and practice of neuropathology. St. Louis: Mosby, 1993:123-84.
10. Castillo M, Scatliff JH, Bouldin TW, Suzuki K. Radiologic-pathologic correlation: Intracranial astrocytoma. AJNR 1992;13: 1609-16.
11. Earnest F, Kelly PJ, Scheithauer BW, et al. Cerebral astrocytomas: Histopathologic correlation of MR and CT contrast enhancement with stereotatic biopsy. Radiology 1988;166:823-7.
12. Castillo M. Contrast enhancement in primary tumors of the brain and spinal cord. Neuroimag Clin North Am 1994;4:63-80.
13. Lenskinski RE, Schnall MD. MR spectroscopy and the biochemical basis of neurologic disease. In: Atlas SW, ed. Magnetic resonance imaging of the brain and spine, 2nd ed. Philadelphia: Lippincott-Raven, 1996:1619-54.
14. Bruhn H, Frahm J, Gyngell ML, et al. Nonvinvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: Initial experience in patients with cerebral tumors. Radiology 1989;172: 541-8.
15. Poptani H, Gupta RK, Roy R, et al. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR 1995;16: 1593-1603.
16. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectrscopic imaging: Clinical relevance. Radiology 1992;185:675-86.
17. Tien RD, Lai PH, Smith JS, Lazeyras F. Single voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJR 1996;167:201-9.
18. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-52.
19. Kugel H, Heindel W, Ernestus RI, et al. Human brain tumors: Spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-9.
20. Demaerel P, Johannik K, Van Hecke P, et al. Localized 1H NMR spectroscopy of fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991;15:67-76.
21. Luyten PR, Marien AJH, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176:791-9.
22. Negendank W. Studies of human brain tumors by MRS: A review. NMR Biomed 1992;5:305-24.
23. Remy C, Grand S, Lai ES, et al. 1H MRS of human brain abscesses in vivo and in vitro. Magn Reson Med 1995;34:508-14.
24. Kuesel AC, Donnelly SM, Halliday W, Sutherland GR, Smith IC. Mobile lipids and metabolic heterogeneity of brain tumors as detectable by ex vivo 1H MR spectroscopy. NMR Biomed 1994;7:172-80.
25. Kuesel AC, Sutherland GR, Halliday W, Smith IC. 1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue. NMR Biomed 1994;7:149-55.
26. Lim YJ, Chang KH, Song IC, et al. Brain abscess and necrotic or cystic brain tumor: Discrimination with signal intensity on diffusion-weighted MR imaging. AJR 1998;171:1487-90.
27. Dooms GC, Hecht S, Brant-Zawadzki M, Berthiaume Y, Norman D, Newton TH. Brain radiation lesions: MR imaging. Radiology 1986; 158:149-55.
28. Holman BL, Abdel-Dayem H. The clinical role of SPECT in patients with brain tumors. J Neuroimaging 1995;5:34-9.
29. Vertosick FT, Selker RG, Grossman SJ, Joyce JM. Correlation of thallium-201 photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurgery 1994;34:396-401.
30. Kahn D, Follet KA, Bushnell DL, Nathan MA, Piper JG, Madsen M. Diagnosis of recurrent brain tumor: Value of 201 T1 SPECT vs 18F-fluorodeoxyglucose PET. AJR 1994;163:1459-65.
31. Gober JR. Noninvasive tissue characterization of brain tunor and radiation therapy using magentic resonance spectroscopy. Neuroimaging Clin North Am 1993;3:779-802.
32. Gupta RK, Poptani H, Kohli A, Chhabra DK, Sharma B, Gujral RB. In vivo localized proton magnetic resonance spectroscopy in intracrnial tuberculomas. Indian J Med Res 1995;101:19-24.
33. Buetow MP, Buetow PC, Smirniotopoulos JG. Typical, atypical, and misleading features in meningioma. RadioGraphics 1991;11:1087-106.
34. Mellati AA, Yucel M, Altinors N, Gunduz U. Regulation of M2-type pyruvate kinase from human meningioma by allosteric effectors fructose 1,6 diphosphate and L-alanine. Cancer Biochem Biophys 1992;13:33-41.
35. Roman-Goldstein SM, Goldman DL, Howieson J, et al. MR in primary CNS lymphoma in immunologically normal patients. AJNR 1992;13:1207-13.
36. Ruiz A, Ganz WI, Post MJD, et al. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. AJNR 1994;15:1885-94.
37. Bizzi A, Movsas B, Tedeschi G, et al. Response of non-Hodgkin lymphoma to radiation therapy: Early and long-term assessment with H-1 MR spectroscopic imaging. Radiology 1995;194:271-6.
38. Bourgouin PM, Tampieri D, Grahovac SZ, et al. CT and MR imaging findings in adults with cerebellar medulloblastoma: Comparison with findings in children. AJR 1992;159:609-2.
39. Wang Z, Sutton LN, Cnaan A, et al. Proton MR spectroscopy of pediatric cerebellar tumors. AJNR 1995;16:1821-33.
40. Preul MC, Caramanos Z, Collins DL, et al. Linear discriminant analysis based on proton MR spectrocopic imaging of human tumours improves pre-operative diagnosis. Nature Med 1996;2:323-5.
41. Somorjai RL, Dolenko B, Nikulin AK, et al. Classification of 1H MR spectra of human brain neoplasms: The influence of preprocessing and computerized consensus diagnosis on classification accuracy. J Magn Reson Imaging 1996;6:431-44.
42. Somorjai RL, Nikulin AE, Pizzi N, et al. Computerized consensus diagnosis: A classification strategy for the robust analysis of MR spectra. I. Application of the 1H spectra of thyroid neoplasms. Magn Reson Med 1995;33:257-63.